Abbott Laboratories buy The Goldman Sachs Group, Inc.
Start price
04.03.25
/
50%
€133.42
Target price
04.03.26
€146.25
Performance (%)
-19.07%
Price
16.12.25
€107.98
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -19.07%. This prediction currently runs until 04.03.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 4.194% | 4.194% |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $138.00 to $154.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by The_Goldman_Sachs_Gr for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€115.08
01.10.25
01.10.25
€133.73
01.10.26
01.10.26
-6.17%
16.12.25
16.12.25
